Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES) (SPORTVAGPRES)

September 2, 2024 updated by: Comenius University

Femfit® and an Innovative Pad Test to Assess Pelvic Floor Muscle Activation During Physical Activity in Sportwoman with and Without SUI - a Pilot Study

To compare the impact of selected physical activities on pelvic floor and stress urinary incontinence in sportwoman.

Study Overview

Detailed Description

This is an observational comparative pilot study in which we will compare intravaginal and intra-abdominal pressure and an innovative pad test in 5 female athletes with stress urinary incontinence and 5 without incontinence.

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Martin, Slovakia, 03659
        • Department of Urology, Jessenius Faculty of Medicine, Martin, Comenius University Bratislava, Slovak Republic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

sportwoman with high intensity of physical activity with and without stress urinary incontinence

Description

Inclusion criteria

  • nulliparous women
  • aged 18-35
  • high-intensity physical activity
  • performed sport at least three days per week, 90 minutes per day, for more than two years

Exclusion Criteria:

  • handicapped sportswomen
  • performance of various kinds of sport
  • no regular sport activity
  • performance of sports for less than two years
  • after childbirth
  • surgical treatment of gynaecological and urological illnesses
  • urinary tract infection
  • disease of respiratory tract
  • not sufficiently completed questionnaires
  • refusal to participate
  • body mass index greater than 30 (BMI = m/h2, where m = body weight in kilograms and h = body height in metres)
  • symptoms of overactive bladder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
sportwoman with high intensity of physical activity with stress urinary incontinence
High-intensity of regular physical activity at least three days per week, 90 minutes per day, for more than two years.
Change in intravaginal and intra-abdominal pressure assessed by Femfit® , leakage of urine in grams assessed by inovative pad test during 5 sports activities.
Other Names:
  • intravaginal and intra-abdominal pressure with Femfit® device during (squeeeze, knack, rapid contractions, endurance contracions)
  • inovative pad test during (jumps on the ground, jumps on a trampoline, weightlifting, slow running, fast running
sportwoman with high intensity of physical activity without stress urinary incontinence
High-intensity of regular physical activity at least three days per week, 90 minutes per day, for more than two years.
Change in intravaginal and intra-abdominal pressure assessed by Femfit® , leakage of urine in grams assessed by inovative pad test during 5 sports activities.
Other Names:
  • intravaginal and intra-abdominal pressure with Femfit® device during (squeeeze, knack, rapid contractions, endurance contracions)
  • inovative pad test during (jumps on the ground, jumps on a trampoline, weightlifting, slow running, fast running

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To measure intravaginal and intra-abdominal pressure with Femfit® device in sportwoman with and wihout Stress Urinary Incontinence.
Time Frame: During the performance of sporting activities up to 60 minutes.
Intravaginal and intra-abdominal pressure will be measured in mmHg.
During the performance of sporting activities up to 60 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To detect the amount of urine leakage by an innovative pad test in sportwoman.
Time Frame: During the performance of sporting activities up to 60 minutes.
Leakage of urine will be measured by weight of pad in grams.
During the performance of sporting activities up to 60 minutes.
To detect the degree of urinary leakage by the International Consultation on Incontinence Questionnaire in sportwoman.
Time Frame: During the performance of sporting activities up to 60 minutes.
Degree of leakage of urine will be measured by the International Consultation on Incontinence Questionnaire short form in score.
During the performance of sporting activities up to 60 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Magdaléna Hagovská, Dr., PhD, Faculty of Medicine, PJ Safarik University, Kosice, Slovak Republic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2023

Primary Completion (Actual)

February 14, 2024

Study Completion (Actual)

March 28, 2024

Study Registration Dates

First Submitted

December 13, 2023

First Submitted That Met QC Criteria

January 17, 2024

First Posted (Actual)

January 25, 2024

Study Record Updates

Last Update Posted (Estimated)

September 5, 2024

Last Update Submitted That Met QC Criteria

September 2, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

On request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence

Subscribe